Dimyristoylphosphatidylcholine

apolipoprotein E ; Homo sapiens







45 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 31913846 The redox status of cysteine thiol residues of apolipoprotein E impacts on its lipid interactions. 2020 Apr 28 2
2 21219628 Structural and functional characterization of human apolipoprotein E 72-166 peptides in both aqueous and lipid environments. 2011 Jan 10 1
3 21322570 Dissociation of apolipoprotein E oligomers to monomer is required for high-affinity binding to phospholipid vesicles. 2011 Apr 5 1
4 21699199 Self-association and stability of the ApoE isoforms at low pH: implications for ApoE-lipid interactions. 2011 Jul 26 1
5 21712092 A simple approach for human recombinant apolipoprotein E4 expression and purification. 2011 Oct 2
6 20030366 Decoding of lipoprotein-receptor interactions: properties of ligand binding modules governing interactions with apolipoprotein E. 2010 Feb 16 3
7 18201068 Contributions of the carboxyl-terminal helical segment to the self-association and lipoprotein preferences of human apolipoprotein E3 and E4 isoforms. 2008 Mar 4 2
8 18959431 Biophysical properties of apolipoprotein E4 variants: implications in molecular mechanisms of correction of hypertriglyceridemia. 2008 Nov 25 4
9 17258176 Anionic phospholipids inhibit apolipoprotein E--low-density lipoprotein receptor interactions. 2007 Mar 16 3
10 17715945 A monomeric, biologically active, full-length human apolipoprotein E. 2007 Sep 18 1
11 16467279 Characterization of low density lipoprotein receptor ligand interactions by fluorescence resonance energy transfer. 2006 May 8
12 16540478 Structural and functional variations in human apolipoprotein E3 and E4. 2006 May 12 1
13 15588256 Orientation and mode of lipid-binding interaction of human apolipoprotein E C-terminal domain. 2005 May 1 3
14 15708851 Examination of lipid-bound conformation of apolipoprotein E4 by pyrene excimer fluorescence. 2005 Apr 15 1
15 15109264 A monomeric human apolipoprotein E carboxyl-terminal domain. 2004 May 4 1
16 12588864 Characterization of the heparin binding sites in human apolipoprotein E. 2003 Apr 25 1
17 12633731 Homo- and hetero-complexes of exchangeable apolipoproteins in solution and in lipid-bound form. 2003 Mar 15 5
18 12646385 Lipid binding ability of human apolipoprotein E N-terminal domain isoforms: correlation with protein stability? 2003 1
19 12950167 Domains of apoE required for binding to apoE receptor 2 and to phospholipids: implications for the functions of apoE in the brain. 2003 Sep 9 3
20 12364553 Influence of apoE domain structure and polymorphism on the kinetics of phospholipid vesicle solubilization. 2002 Oct 3
21 11369796 Effects of polymorphism on the microenvironment of the LDL receptor-binding region of human apoE. 2001 Jun 9
22 10751422 Structural determinants in the C-terminal domain of apolipoprotein E mediating binding to the protein core of human aortic biglycan. 2000 Jun 23 4
23 10801877 Conformational reorganization of the four-helix bundle of human apolipoprotein E in binding to phospholipid. 2000 Jul 7 4
24 10921925 Effects of lipid interaction on the lysine microenvironments in apolipoprotein E. 2000 Nov 3 4
25 9869654 Lipid binding-induced conformational changes in the N-terminal domain of human apolipoprotein E. 1999 Jan 1
26 9643348 The carboxyl terminus in apolipoprotein E2 and the seven amino acid repeat in apolipoprotein E-Leiden: role in receptor-binding activity. 1998 Jun 1
27 9699892 Apolipoprotein E and regulation of cytokine-induced cell adhesion molecule expression in endothelial cells. 1998 Jul 3
28 8995232 Apolipoprotein E inhibits platelet aggregation through the L-arginine:nitric oxide pathway. Implications for vascular disease. 1997 Jan 3 10
29 9054055 Inhibition of ADP-induced platelet aggregation by apoE is not mediated by membrane cholesterol depletion. 1996 Mar 1 2
30 7662677 Comparison of lipid-binding and lecithin:cholesterol acyltransferase activation of the amino- and carboxyl-terminal domains of human apolipoprotein E3. 1995 Aug 29 1
31 7706948 Identification and characterization of a novel apolipoprotein E variant, apolipoprotein E3' (Arg136-->His): association with mild dyslipidemia and double pre-beta very low density lipoproteins. 1995 Jan 2
32 8610278 Inhibition of ADP-induced platelet aggregation by apoE is not mediated by membrane cholesterol depletion. 1995 Dec 15 2
33 1613982 [Amplification and inhibition of platelet function by serum lipoproteins]. 1992 Feb 5
34 1734956 Apolipoprotein E: phospholipid binding studies with synthetic peptides from the carboxyl terminus. 1992 Feb 4 3
35 2026270 The role of apoE in inhibitory effects of apoE-rich HDL on platelet function. 1991 Apr 22 9
36 2168737 Effect of particle size and temperature on the conformation and physiological behavior of apolipoprotein E bound to model lipoprotein particles. 1990 Jul 17 3
37 3167047 Lipolysis of phospholipids in model cholesteryl ester rich lipoproteins and related systems: effect of core and surface lipid phase state. 1988 Jul 12 1
38 3360782 Human apolipoprotein E3 in aqueous solution. II. Properties of the amino- and carboxyl-terminal domains. 1988 May 5 1
39 3026456 Motion and surface accessibility of spin-labeled lipids in a model lipoprotein containing cholesteryl oleate, dimyristoylphosphatidylcholine, and apolipoprotein E. 1986 Nov 18 1
40 3827833 Metabolism of apolipoprotein E-containing human plasma lipoproteins by rat and human cells in culture. 1986 Nov 15 2
41 4054131 Activation of phosphatidylcholine-sterol acyltransferase by human apolipoprotein E isoforms. 1985 Nov 4 1
42 6089844 The conformation of apolipoprotein E isoforms in phospholipid complexes and their interaction with human Hep G2 cells. 1984 Aug 6
43 6327714 Normalization of receptor binding of apolipoprotein E2. Evidence for modulation of the binding site conformation. 1984 Jun 10 4
44 6313653 The receptor-binding domain of human apolipoprotein E. Monoclonal antibody inhibition of binding. 1983 Oct 25 1
45 7068619 Apoprotein E suppresses phytohemagglutinin-activated phospholipid turnover in peripheral blood mononuclear cells. 1982 May 25 2